The Revised International Prognostic Index (R-IPI) is an ASSESSMENT TOOL.
The Revised International Prognostic Index is used to determine prognosis in PATIENTS with Diffuse Large B-cell Lymphoma (DLBCL) and is derived from:
For further information on the Revised International Prognostic Index, see the Revised International Prognostic Index calculator.
This supporting information is also known by these names:
Context | Alias |
---|---|
shortname | R-IPI |